Sideman, Alissa Bernstein
Nguyen, Huong Q.
Langer-Gould, Annette
Lee, Eric A.
Borson, Soo
Shen, Ernest
Tsoy, Elena
Macias, Mayra
Goode, Collette
Rankin, Katherine
Kramer, Joel
Possin, Katherine L.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (U01NS128913)
National Institute of Neurological Disorders and Stroke (U01NS128913)
National Institute of Neurological Disorders and Stroke (U01NS128913)
National Institute of Neurological Disorders and Stroke (U01NS128913)
National Institute of Neurological Disorders and Stroke (U01NS128913)
National Institute of Neurological Disorders and Stroke (U01NS128913)
National Institute of Neurological Disorders and Stroke (U01NS128913)
National Institute of Neurological Disorders and Stroke (U01NS128913)
National Institute of Neurological Disorders and Stroke (U01NS128913)
National Institute of Neurological Disorders and Stroke (U01NS128913)
National Institute of Neurological Disorders and Stroke (U01NS128913)
National Institute of Neurological Disorders and Stroke (U01NS128913)
Article History
Received: 7 June 2024
Accepted: 25 July 2024
First Online: 6 August 2024
Declarations
:
: All study methods were carried out in accordance with relevant human subjects protection guidelines and regulations in the United States. The Institutional Review Boards of Kaiser Permanente Southern California (#13451) and University of California, San Francisco (#23-40220) approved a waiver of written consent for the trial (clinicaltrials.gov: NCT06090578; registered 10/24/23). Verbal consent was obtained from the physician and administrative leaders who participated in the site visit interviews.
: Not applicable.
: The authors declare no competing interests.